AcelRx Pharmaceuticals Inc (ACRX) stock is down -20.09% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ACRX stock a score of 72 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 91. ACRX's rank also includes a fundamental score of 85. In addition to the average rating from Wall Street analysts, ACRX stock has a mean target price of 6. This means analysts expect the stock to add 242.86% over the next 12 months. The short-term technical score for ACRX is 40.
What's Happening with ACRX Stock Today
AcelRx Pharmaceuticals Inc (ACRX) stock is higher by 2.34% while the S&P 500 is down -0.3% as of 4:00 PM on Tuesday, Oct 27. ACRX is higher by $0.04 from the previous closing price of $1.71 on volume of 1,363,748 shares. Over the past year the S&P 500 is up 11.56% while ACRX is down -20.09%. ACRX lost -$0.62 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on AcelRx Pharmaceuticals Inc (ACRX) Stock.
